Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details)

v3.22.1
Subsequent Events (Details) - Subsequent Event
$ in Millions
May 11, 2022
USD ($)
Invagen Pharmaceuticals Inc  
Percentage of repurchase of ownership interest 100.00%
Fortress | Contribution Agreement  
Ownership percentage transferred 100.00%
Fortress | Contribution Agreement | Minimum  
Proceeds from equity financing $ 7.5